Gyre Therapeutics, Inc. (GYRE)

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $140.62M in the twelve months ending March 31, 2024, with 11.23% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $27.17M with 8.99% year-over-year growth. In the year 2023, Gyre Therapeutics had annual revenue of $113.45M with 10.91% growth.

• Revenue (ttm): $140.62M
• Revenue Growth: +11.23%
• P/S Ratio: 7.35
• Revenue / Employee: $237,137
• Employees: 593
• Market Cap: 1.03B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	113.45M	11.16M	10.91%
Dec 31, 2022	102.29M	94.95M	1,293.98%
Dec 31, 2021	7.34M	-13.61M	-64.97%
Dec 31, 2020	20.95M	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	1.02M	619.00K	155.14%
Dec 31, 2016	399.00K	-1.35M	-77.20%
Dec 31, 2015	1.75M	-63.00K	-3.47%
Dec 31, 2014	1.81M	1.29M	246.65%
Dec 31, 2013	523.00K	-57.34M	-99.10%
Dec 31, 2012	57.86M	-39.78M	-40.74%
Dec 31, 2011	97.64M	11.92M	13.91%
Dec 31, 2010	85.71M	60.65M	242.00%
Dec 31, 2009	25.06M	4.98M	24.78%
Dec 31, 2008	20.09M	8.51M	73.51%
Dec 31, 2007	11.58M	-15.96M	-57.96%
Dec 31, 2006	27.54M	26.36M	2,233.81%
Dec 31, 2005	1.18M	-2.56M	-68.44%
Dec 31, 2004	3.74M	1.28M	52.07%
Dec 31, 2003	2.46M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.